Have questions, need support, or want to learn more about our AI-driven diagnostics platform?
Our technology has been clinically validated with accuracy comparable to traditional OSA screening tools. The AI-powered analysis detects subtle facial features and patterns associated with OSA risk factors, helping identify individuals who may benefit from further evaluation.
No. The Soliish scan is a screening tool, not a diagnostic device. It identifies individuals who may be at risk for obstructive sleep apnea (OSA) and guides them toward appropriate diagnostic testing such as a home sleep test or polysomnography.
Once the screening is complete, users receive an OSA risk score classified as low, moderate, or high risk. Those identified at risk can be directed to a licensed provider or home sleep test for diagnostic confirmation and care planning. The goal is to simplify the path from awareness to diagnosis and treatment.
No. FaceX runs through any standard web browser on a smartphone, tablet, or desktop with a camera. No wearable device, no overnight test, and no app download are required. The entire screening takes under 60 seconds.
Yes. All data is stored on secure, HIPAA-compliant US-based servers, encrypted at rest and in transit. Soliish also aligns with GDPR for international partners. Patient data is never used for marketing or resold to third parties.
Yes. Soliish supports HL7 and FHIR standards for EHR integration, as well as REST API, embedded SDK, iFrame deployment, and Zapier-based no-code workflows. Most integrations require no custom development.
Yes. Soliish offers flexible branding options from co-branded experiences to fully white-labeled deployments with your domain and custom workflows. Contact our team to discuss your specific requirements.
Approximately 936 million people worldwide are affected by obstructive sleep apnea, with an estimated 80% remaining undiagnosed. The average time from symptom onset to clinical diagnosis is 2 to 5 years.